My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 232

    1.

    Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences.

    Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH.

    Ann Intern Med. 2001 Feb 6;134(3):224-38. Review.PMID: 11177336 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Atherothrombosis: epidemiology, pathophysiology, and prevention.

    Munger MA, Hawkins DW.

    J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2 Suppl 1):S5-12; quiz S12-3. Review.PMID: 15095931 [PubMed - indexed for MEDLINE]Related articles

    3.

    Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.

    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.

    Thromb Haemost. 2007 Mar;97(3):435-43.PMID: 17334511 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antiplatelet therapy and anticoagulation in patients with hypertension.

    Griffin G.

    Am Fam Physician. 2005 Mar 1;71(5):897-9. Review.PMID: 15768617 [PubMed - indexed for MEDLINE]Related articles

    5.

    New targets for antithrombotic drugs.

    Thiagarajan P.

    Am J Cardiovasc Drugs. 2002;2(4):227-35. Review.PMID: 14727968 [PubMed - indexed for MEDLINE]Related articles

    6.

    New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.

    Spinler SA, Hilleman DE, Cheng JW, Howard PA, Mauro VF, Lopez LM, Munger MA, Gardner SF, Nappi JM.

    Ann Pharmacother. 2001 May;35(5):589-617. Review.PMID: 11346067 [PubMed - indexed for MEDLINE]Related articles

    7.

    Therapeutic approaches in arterial thrombosis.

    Phillips DR, Conley PB, Sinha U, Andre P.

    J Thromb Haemost. 2005 Aug;3(8):1577-89. Review.PMID: 16102022 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

    Hermosillo AJ, Spinler SA.

    Ann Pharmacother. 2008 Jun;42(6):790-805. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521. PMID: 18477734 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antiplatelet agents and anticoagulants for hypertension.

    Lip GY, Felmeden DC.

    Cochrane Database Syst Rev. 2004;(3):CD003186. Review.PMID: 15266473 [PubMed - indexed for MEDLINE]Related articles

    10.

    Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

    Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

    Semin Thromb Hemost. 2008 Feb;34(1):58-73. Review.PMID: 18393143 [PubMed - indexed for MEDLINE]Related articles

    11.

    Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy.

    Sakariassen KS, Hanson SR, Cadroy Y.

    Thromb Res. 2001 Nov 1;104(3):149-74. Review.PMID: 11672758 [PubMed - indexed for MEDLINE]Related articles

    12.

    Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a review.

    Truong KM, Amankwa K, Kucukarslan S.

    Clin Ther. 2001 Aug;23(8):1145-65; discussion 1129. Review.PMID: 11558855 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.

    Chung TL, Pumplin DW, Holton LH 3rd, Taylor JA, Rodriguez ED, Silverman RP.

    Plast Reconstr Surg. 2007 Oct;120(5):1281-8.PMID: 17898601 [PubMed - indexed for MEDLINE]Related articles

    14.

    Plaque rupture, thrombosis, and therapeutic implications.

    Fuster V, Badimon J, Chesebro JH, Fallon JT.

    Haemostasis. 1996 Oct;26 Suppl 4:269-84. Review.PMID: 8979133 [PubMed - indexed for MEDLINE]Related articles

    15.

    Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

    Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L.

    Circulation. 1999 Apr 13;99(14):1780-7.PMID: 10199872 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.

    Monroe VS, Kerensky RA, Rivera E, Smith KM, Pepine CJ.

    J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):23S-30S. Review.PMID: 12644337 [PubMed - indexed for MEDLINE]Related articles

    17.

    Platelet glycoprotein IIb/IIIa receptor antagonists and coronary artery disease.

    Nguyen-Ho P, Lakkis NM.

    Curr Atheroscler Rep. 2001 Mar;3(2):139-48. Review.PMID: 11177658 [PubMed - indexed for MEDLINE]Related articles

    18.

    Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents.

    Goto S.

    Curr Vasc Pharmacol. 2004 Jan;2(1):23-32. Review.PMID: 15320830 [PubMed - indexed for MEDLINE]Related articles

    19.

    The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.

    Bolognese L.

    Curr Med Res Opin. 2007 Jun;23(6):1217-26. Epub 2007 Apr 23. Review.PMID: 17559721 [PubMed - indexed for MEDLINE]Related articles

    20.

    The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.

    Lee DS, Bhatt DL, Moliterno DJ, Peacock WF, Ellis SG, Topol EJ.

    J Invasive Cardiol. 2004 Feb;16(2):46-51.PMID: 14760188 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity